A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis

Gastroenterology

Matthew R Henn, Edward J O’Brien, Liyang Diao, …, Bharat K Misra, John G Auninš, Michele Trucksis

• DOI: 10.1053/j.gastro.2020.07.048
• PMID: 32763240
• PMCID: PMC7402096